Log in
NASDAQ:AYTU

Aytu BioScience Stock Forecast, Price & News

$0.95
-0.03 (-3.06 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.91
Now: $0.95
$0.98
50-Day Range
$0.96
MA: $1.15
$1.38
52-Week Range
$0.34
Now: $0.95
$2.99
Volume1.80 million shs
Average Volume10.76 million shs
Market Capitalization$119.58 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.29
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AYTU
CUSIPN/A
CIKN/A
Phone720-437-6580
Employees61

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.63 million
Book Value$0.79 per share

Profitability

Net Income$-13,620,000.00

Miscellaneous

Market Cap$119.58 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$0.95
-0.03 (-3.06 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AYTU News and Ratings via Email

Sign-up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aytu BioScience (NASDAQ:AYTU) Frequently Asked Questions

How has Aytu BioScience's stock price been impacted by Coronavirus (COVID-19)?

Aytu BioScience's stock was trading at $1.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AYTU shares have decreased by 29.6% and is now trading at $0.9503.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Aytu BioScience?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aytu BioScience in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aytu BioScience
.

When is Aytu BioScience's next earnings date?

Aytu BioScience is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Aytu BioScience
.

How were Aytu BioScience's earnings last quarter?

Aytu BioScience, Inc. (NASDAQ:AYTU) issued its quarterly earnings data on Thursday, May, 14th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.07. The business had revenue of $8.16 million for the quarter, compared to the consensus estimate of $7 million. Aytu BioScience had a negative net margin of 49.29% and a negative return on equity of 37.62%.
View Aytu BioScience's earnings history
.

When did Aytu BioScience's stock split? How did Aytu BioScience's stock split work?

Aytu BioScience's stock reverse split on the morning of Tuesday, August 29th 2017. The 1-20 reverse split was announced on Friday, August 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 28th 2017. An investor that had 100 shares of Aytu BioScience stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for AYTU?

2 Wall Street analysts have issued 1 year price targets for Aytu BioScience's shares. Their forecasts range from $3.00 to $5.00. On average, they expect Aytu BioScience's stock price to reach $4.00 in the next year. This suggests a possible upside of 320.9% from the stock's current price.
View analysts' price targets for Aytu BioScience
.

Are investors shorting Aytu BioScience?

Aytu BioScience saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 11,450,000 shares, an increase of 129.0% from the September 15th total of 5,000,000 shares. Based on an average daily trading volume, of 4,440,000 shares, the days-to-cover ratio is presently 2.6 days.
View Aytu BioScience's Short Interest
.

Who are some of Aytu BioScience's key competitors?

What other stocks do shareholders of Aytu BioScience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aytu BioScience investors own include Sorrento Therapeutics (SRNE), Vaxart (VXRT), ADMA Biologics (ADMA), Heat Biologics (HTBX), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV), Ibio (IBIO), Matinas BioPharma (MTNB), BioNano Genomics (BNGO) and SCYNEXIS (SCYX).

Who are Aytu BioScience's key executives?

Aytu BioScience's management team includes the following people:
  • Mr. Joshua R. Disbrow, Chairman & CEO (Age 45, Pay $465k)
  • Mr. David A. Green, CFO, Sec. & Treasurer (Age 57, Pay $345k)
  • Mr. Jarrett T. Disbrow Ph.D., Exec. VP of Corp. Devel. (Age 45, Pay $355k)
  • Mr. Matthew V. Phillips, Exec. VP of Commercial Operations (Age 52)

What is Aytu BioScience's stock symbol?

Aytu BioScience trades on the NASDAQ under the ticker symbol "AYTU."

Who are Aytu BioScience's major shareholders?

Aytu BioScience's stock is owned by many different institutional and retail investors. Top institutional shareholders include Beech Hill Advisors Inc. (0.02%). Company insiders that own Aytu BioScience stock include Armistice Capital Master Fund, David A Green and Joshua R Disbrow.
View institutional ownership trends for Aytu BioScience
.

Which institutional investors are buying Aytu BioScience stock?

AYTU stock was bought by a variety of institutional investors in the last quarter, including Beech Hill Advisors Inc.. Company insiders that have bought Aytu BioScience stock in the last two years include Armistice Capital Master Fund, and Joshua R Disbrow.
View insider buying and selling activity for Aytu BioScience
.

How do I buy shares of Aytu BioScience?

Shares of AYTU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aytu BioScience's stock price today?

One share of AYTU stock can currently be purchased for approximately $0.95.

How big of a company is Aytu BioScience?

Aytu BioScience has a market capitalization of $119.58 million and generates $27.63 million in revenue each year. The company earns $-13,620,000.00 in net income (profit) each year or ($3.48) on an earnings per share basis. Aytu BioScience employs 61 workers across the globe.

What is Aytu BioScience's official website?

The official website for Aytu BioScience is aytubio.com.

How can I contact Aytu BioScience?

Aytu BioScience's mailing address is 373 INVERNESS PARKWAY SUITE 206, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-437-6580 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.